About this event
This two-part webinar will update clinicians on the revised CESEL Type 2 diabetes guide and accompanying SEL GLP-1 guidance, incorporating the NICE February 2026 recommendations and the shift towards earlier cardio-renal-metabolic risk reduction. Session 1 will focus on the increased role and appropriate prescribing of SGLT2 inhibitors, while Session 2 will explore GLP-1 receptor agonists, including initiation and titration. Both sessions will also highlight current treatment targets, care processes, and where to access relevant guidance and resources.
Hosted by
Education, Professional Development and Workforce provider across Primary Care in South East London